← FDA Drug Approvals (Drugs@FDA)

SILODOSIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2020-02-14

Drug application

FDA Application #

ANDA204793

Application type

Abbreviated New Drug Application (Generic)

Brand name

SILODOSIN

Generic name

SILODOSIN

Active ingredients

SILODOSIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD V

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2020-02-14

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown